GSK’s Shingrix Shows Positive Results in Phase 3 Trial November 2, 2015 The shingles vaccine demonstrated 90 percent efficacy in adults 70 years of age and older. Read More
Merck’s Lung Cancer Drug Shows Survival Benefit in Study October 30, 2015 The phase 2/3 trial met primary survival endpoints. Read More
EFPIA Calls for Development of Antibiotics for Human Use Only October 29, 2015 Companies should avoid the overuse of antibiotics in animals. Read More
WHO Recommends Pilot Tests of GSK’s Malaria Vaccine October 29, 2015 WHO would like to see three to five large demonstration projects. Read More
Zafgen to Continue Prader-Willi Syndrome Trial Despite Patient Death October 28, 2015 The FDA will review results from the trial and a Phase 2b study. Read More
AZ, Lilly Expand Immuno-Oncology Collaboration October 28, 2015 Both firms will evaluate safety and efficacy of drug combinations. Read More
Healthcare Research Firms Team Up on Late-Stage Real-World Evidence Initiative October 22, 2015 Quintiles is partnering with IMS Health to boost real-world assessments of drug products in late-stage clinical trials. Read More
Rebiotix Wins Breakthrough Therapy Designation forRBX2660 October 20, 2015 The treatment is indicated for Clostridium difficile infection. Read More
Cancer Research UK Pledges $154 Million to Research Cancer Treatments October 16, 2015 The grants are open to researchers worldwide in industry and academia. Read More